文献速递慢病管理老年与多病共存

改良剑桥多病共存评分(SNOMED CT版)的开发与验证

Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study.
PubMed 文献 · Br J Gen Pract · 2023-05-25

本研究利用2014–2019年英格兰初级保健哨点监测网络的诊断与处方数据,开发并验证了基于SNOMED CT临床术语的改良剑桥多病共存评分。研究在30万人的开发数据集中建模,最终保留21种健康状况的变量缩减模型在15万人同期验证集和15万人非同期验证集中均表现良好,对1年及5年死亡风险具有高区分度和良好校准。

要点

  • 改良版剑桥多病共存评分基于SNOMED CT术语,可在国际多种医疗环境中应用。
  • 最终变量缩减模型保留21种健康状况,与原始20病种模型高度重叠。
  • 模型对1年及5年死亡风险显示高区分度和良好校准。

核心结论

  • 改良版剑桥多病共存评分使用SNOMED CT临床术语,可跨国际多种医疗环境可靠估计多病共存患者的死亡风险。

研究设计与样本

  • 观察性研究,使用2014–2019年英格兰初级保健哨点监测网络的诊断与处方数据。
  • 开发数据集n=300 000,同期验证数据集n=150 000,非同期验证数据集n=150 000。
  • 采用Cox比例风险模型建模,并开发20病种简化模型及基于AIC后向 elimination的变量缩减模型。

主要发现

  • 最终变量缩减模型保留21种健康状况,与20病种模型的条件大部分重叠。
  • 变量缩减模型性能与37病种和20病种模型相似,显示高区分度,重新校准后校准良好。
  • 模型在同期验证集中验证1年死亡率,在非同期验证集中验证1年和5年死亡率。

临床怎么用

  • 全科医生可利用基于SNOMED CT的改良剑桥多病共存评分识别高死亡风险的多病共存患者,辅助制定管理策略和资源配置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with multiple health conditions are more likely to have poorer health outcomes and greater care and service needs; a reliable measure of multimorbidity would inform management strategies and resource allocation. AIM: To develop and validate a modified version of the Cambridge Multimorbidity Score in an extended age range, using clinical terms that are routinely used in electronic health records across the world (Systematized Nomenclature of Medicine - Clinical Terms, SNOMED CT). DESIGN AND SETTING: Observational study using diagnosis and prescriptions data from an English primary care sentinel surveillance network between 2014 and 2019. METHOD: In this study new variables describing 37 health conditions were curated and the associations modelled between these and 1-year mortality risk using the Cox proportional hazard model in a development dataset (n = 300 000). Two simplified models were then developed - a 20-condition model as per the original Cambridge Multimorbidity Score and a variable reduction model using backward elimination with Akaike information criterion as the stopping criterion. The results were compared and validated for 1-year mortality in a synchronous validation dataset (n = 150 000), and for 1-year and 5-year mortality in an asynchronous validation dataset (n = 150 000). RESULTS: The final variable reduction model retained 21 conditions, and the conditions mostly overlapped with those in the 20-condition model. The model performed similarly to the 37- and 20-condition models, showing high discrimination and good calibration following recalibration. CONCLUSION: This modified version of the Cambridge Multimorbidity Score allows reliable estimation using clinical terms that can be applied internationally across multiple healthcare settings.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Tsang RS, Joy M, Whitaker H, et al. Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study. Br J Gen Pract. 2023. PMID: 37130611. doi:10.3399/BJGP.2022.0235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。